[Disease-modifying treatment of MS--progress with complications].
Fagius
Jan
J
Neurologiska kliniken, Neurocentrum, Akademiska sjukhuset, Uppsala. jan.fagius@neurologi.uu.se
D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000191:economics; D032921:Consensus; D016527:Drug Costs; D006801:Humans; D016899:Interferon-beta / Q000008:administration & dosage* / Q000191:economics; D009103:Multiple Sclerosis / Q000188:drug therapy*; D017410:Practice Guidelines as Topic
D000276:Adjuvants, Immunologic; D016899:Interferon-beta
Sjukdomsmodifierande behandling mot MS--framsteg med komplikationer.